scholarly article | Q13442814 |
P819 | ADS bibcode | 1993PNAS...90.5843S |
P356 | DOI | 10.1073/PNAS.90.12.5843 |
P932 | PMC publication ID | 46819 |
P698 | PubMed publication ID | 8516335 |
P5875 | ResearchGate publication ID | 14683655 |
P50 | author | Terje Espevik | Q15734296 |
P2093 | author name string | Yao Z | |
Nelson R | |||
Zheng T | |||
Feldman E | |||
Heintz R | |||
Yao Q | |||
Soon-Shiong P | |||
Merideth N | |||
Skjak-Braek G | |||
P2860 | cites work | Microencapsulated islets as bioartificial endocrine pancreas | Q34269177 |
Inducible interleukin-1 gene expression in human vascular smooth muscle cells | Q34548807 | ||
Induction of cytokine production from human monocytes stimulated with alginate | Q34968426 | ||
An immunologic basis for the fibrotic reaction to implanted microcapsules. | Q35012452 | ||
Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities | Q39507424 | ||
The effects of pancreas transplantation on the glomerular structure of renal allografts in patients with insulin-dependent diabetes | Q41293878 | ||
Successful reversal of spontaneous diabetes in dogs by intraperitoneal microencapsulated islets | Q44410668 | ||
Human C-peptide response in xenotransplanted diabetic Lewis rats | Q46319388 | ||
Glucose-insulin kinetics of the extravascular bioartificial pancreas. A study using microencapsulated rat islets | Q51603962 | ||
Effects of Pancreatic Transplantation on Diabetic Neuropathy | Q60681694 | ||
Transplantation of microencapsulated pancreatic human islets for therapy of diabetes mellitus. A preliminary report | Q68054209 | ||
The role of CD4+ helper T cells in the destruction of microencapsulated islet xenografts in nod mice | Q68083681 | ||
Microencapsulated hepatocytes as a bioartificial liver | Q68915313 | ||
Immunoisolation of pancreatic B cells by microencapsulation. An in vitro study | Q69972593 | ||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 5843-5847 | |
P577 | publication date | 1993-06-01 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | Long-term reversal of diabetes by the injection of immunoprotected islets | |
P478 | volume | 90 |
Q28829175 | 3D Cell Culture in Alginate Hydrogels |
Q39051114 | Advances in islet encapsulation technologies |
Q46521466 | Alginate assessment by NMR microscopy |
Q40885387 | Alginate based new materials |
Q34420908 | An encapsulation system for the immunoisolation of pancreatic islets |
Q73483180 | Assessment of insulin secretion in vitro from microencapsulated fetal porcine islet-like cell clusters and rat, mouse, and human pancreatic islets |
Q40587998 | Association between macrophage activation and function of micro-encapsulated rat islets |
Q41296005 | Biocompatibility issues of implantable drug delivery systems |
Q38130163 | Bioengineered sites for islet cell transplantation |
Q38294476 | Biomaterials in tissue engineering |
Q33796406 | Carbohydrates in transplantation |
Q36750715 | Cloning and expression of an Azotobacter vinelandii mannuronan C-5-epimerase gene |
Q39547101 | Cloning and expression of three new Aazotobacter vinelandii genes closely related to a previously described gene family encoding mannuronan C-5-epimerases. |
Q30439009 | Core-shell hydrogel microcapsules for improved islets encapsulation. |
Q74444960 | Culture of chondrocytes in alginate gel: variations in conditions of gelation influence the structure of the alginate gel, and the arrangement and morphology of proliferating chondrocytes |
Q38123626 | Current status of islet encapsulation |
Q47217806 | Designing a retrievable and scalable cell encapsulation device for potential treatment of type 1 diabetes |
Q44236948 | Deterioration of polyamino acid-coated alginate microcapsules in vivo |
Q34187908 | Diabetes mellitus and closed-loop insulin delivery |
Q73118229 | Effects of alginate composition on the metabolic, secretory, and growth characteristics of entrapped beta TC3 mouse insulinoma cells |
Q87411475 | Encapsulate this: the do's and don'ts |
Q45887969 | Encapsulated cell technology |
Q26866524 | Encapsulated islet transplantation: strategies and clinical trials |
Q37106938 | Encapsulation of human islets in novel inhomogeneous alginate-ca2+/ba2+ microbeads: in vitro and in vivo function |
Q44029525 | Encapsulation of insulin in chitosan-coated alginate beads: oral therapeutic peptide delivery |
Q34713899 | Enhanced function of immuno-isolated islets in diabetes therapy by co-encapsulation with an anti-inflammatory drug |
Q48229772 | Evaluation of different types of alginate microcapsules as bioreactors for producing endostatin |
Q44632895 | Factors Influencing Insulin Secretion from Encapsulated Islets |
Q34340699 | Human placenta-derived mesenchymal stem cells and islet-like cell clusters generated from these cells as a novel source for stem cell therapy in diabetes. |
Q34003144 | Immunocompatibility and biocompatibility of cell delivery systems |
Q40427311 | Implantable Biohybrid Artificial Organs |
Q40631516 | Improving cell encapsulation through size control |
Q84090337 | Improving the efficacy of type 1 diabetes therapy by transplantation of immunoisolated insulin-producing cells |
Q52082665 | Inhomogeneous alginate gel spheres: an assessment of the polymer gradients by synchrotron radiation-induced X-ray emission, magnetic resonance microimaging, and mathematical modeling. |
Q29395650 | Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation |
Q40721665 | Involvement of toll-like receptor (TLR) 2 and TLR4 in cell activation by mannuronic acid polymers |
Q74414564 | Is it possible to use the standard alginate-PLL procedure for production of small capsules? |
Q34972386 | Islet and stem cell encapsulation for clinical transplantation |
Q34452096 | Islet cell transplantation for the treatment of diabetes mellitus |
Q45712216 | Islet immunoisolation: experience with biopolymers |
Q37263794 | Islet transplantation: the quest for an ideal source |
Q36666407 | Islets transplanted in immunoisolation devices: a review of the progress and the challenges that remain |
Q40933757 | Lentivirus-mediated Bcl-2 expression in betaTC-tet cells improves resistance to hypoxia and cytokine-induced apoptosis while preserving in vitro and in vivo control of insulin secretion |
Q32043185 | Maintenance of primary murine hepatocyte functions in multicomponent polymer capsules--in vitro cryopreservation studies |
Q29615286 | Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia |
Q34284217 | Microencapsulation of islets within alginate/poly(ethylene glycol) gels cross-linked via Staudinger ligation |
Q34779793 | Microfabrication technology for pancreatic cell encapsulation |
Q30882242 | NMR properties of alginate microbeads |
Q61196605 | Nano-scale encapsulation enhances allograft survival and function of islets transplanted in a mouse model of diabetes |
Q45997189 | Nanoporous Immunoprotective Device for Stem-Cell-Derived β-Cell Replacement Therapy. |
Q45180749 | New technologies for bioartificial organs |
Q36154188 | Non-invasive evaluation of alginate/poly-l-lysine/alginate microcapsules by magnetic resonance microscopy |
Q40472049 | Novel Delivery of Pancreatic Islet Cells to Treat Insulin-Dependent Diabetes Mellitus |
Q40620336 | Pancreas and kidney/pancreas transplants: experimental medicine or real improvement? |
Q37109821 | Polymer-coated cannulas for the reduction of backflow during intraparenchymal infusions. |
Q53614227 | Preparation and microscopy examination of alginate-poly-L-lysine-alginate microcapsules. |
Q38922330 | Self-assembled gold coating enhances X-ray imaging of alginate microcapsules |
Q37896760 | Smart medication through combination of synthetic biology and cell microencapsulation |
Q57348459 | Stimulus-Responsive Polyelectrolyte Particles: From Nanospheres to Macroscopic Beads |
Q47243032 | Studies on small (<350 microm) alginate-poly-L-lysine microcapsules. V. Determination of carbohydrate and protein permeation through microcapsules by reverse-size exclusion chromatography |
Q86660871 | Sustained function of alginate-encapsulated human islet cell implants in the peritoneal cavity of mice leading to a pilot study in a type 1 diabetic patient |
Q41569972 | Synthesis and Evaluation of a Sodium Alginate-4-Aminosalicylic Acid Based Microporous Hydrogel for Potential Viscosupplementation for Joint Injuries and Arthritis-Induced Conditions |
Q50184746 | The effect of hypoxia on free and encapsulated adult porcine islets-an in vitro study |
Q43597024 | The effects of alginate composition on encapsulated betaTC3 cells |
Q43661577 | The isolation and function of porcine islets from market weight pigs |
Q35196565 | The use of biomaterials in islet transplantation |
Q77325493 | Tissue modifications |
Q35057824 | Towards ready-to-use 3-D scaffolds for regenerative medicine: adhesion-based cryopreservation of human mesenchymal stem cells attached and spread within alginate-gelatin cryogel scaffolds |
Q33965029 | Transplantation for the treatment of diabetes mellitus |
Q38630043 | Transplantation of Encapsulated Pancreatic Islets as a Treatment for Patients with Type 1 Diabetes Mellitus |
Q73850458 | Treatment of type I diabetes using encapsulated islets |
Q51190616 | Versatile, cell and chip friendly method to gel alginate in microfluidic devices |
Q71345175 | Xenografts of porcine islets immunoprotected in hollow fibres reduce the incidence of diabetes in non-obese diabetic mice |
Search more.